Deerfield Management

Since the inception of the Ancora Innovations partnership in 2018, Vanderbilt and Deerfield Management have enjoyed a robust collaboration. Deerfield’s commitment includes significant support for advancing translational research and sponsorship of various events across Vanderbilt University and Vanderbilt University Medical Center. Recently, key members of Deerfield's leadership team spent two days at Vanderbilt to engage faculty in discussions about potential projects of mutual interest.  Read More

The CMT Research Foundation, a non-profit focused solely on delivering treatments and cures for Charcot-Marie-Tooth disease*, has invested in a project at Vanderbilt University School of Medicine Basic Sciences that seeks to treat the problem of overproduction of PMP22, the primary genetic cause of CMT in patients with CMT1A. Read More

Appello was established with major investment from New York-based Deerfield Management, which specializes in accelerating drug development projects at universities and other nonprofits. Read More